Multiple Paths Can Lead to Cybersecurity Success 
Instruct3D Strengthens Additive Build Intelligence Message Following ICAM 2026 
Otto Group and Sereact Bring NVIDIA-Powered Physical AI to Returns Processing Empower Announces DTC Eligibility
Company Stock Is Now More Accessible to U.S. Investors VANCOUVER B.C. / ACCESSWIRE / April…
Tiffany Ongtenco Talks to IdeaMensch In New Exclusive Interview
General Manager of Northfleet Concrete Floors, Inc., Tiffany Ongtenco, discusses how she’s found fulfillment in…
Panasonic TOUGHBOOK Appoints Michael Willett As UK Logistics and Manufacturing Lead
Aims to improve mobile workforce productivity across the supply chain with Panasonic TOUGHBOOK rugged solutions….
cinch partners with Talent Works to expand Manchester tech hub as online car sales accelerate
The UK’s fastest growing online used car marketplace selects Talent Works as a recruitment partner…
AWS Premier Consulting Partner, HeleCloud, Strengthens Position as Leading AWS Consultancy by Appointing a Chief Technology Officer
London, 15 April 2021: HeleCloud, an AWS Premier Consulting Partner based in the UK, Bulgaria…
Paddle appoints Jimmy Fitzgerald as President and Chief Operating Officer to drive next stage of global growth
Software industry veteran joins fast growing Revenue Delivery Platform for B2B SaaS London & New…
ImCheck Therapeutics Appoints Dr. Loui Madakamutil as CSO
ImCheck Therapeutics Appoints Dr. Loui Madakamutil, Noted Expert in Immunology and Autoimmune Diseases, as Chief…
While ElsaLys continues to work on the filing of marketing approval in Europe and the U.S. for inolimomab, the company confirms the renew of its cohort ATU in France and compassionate use programs submissions in several other countries
While ElsaLys continues to work on the filing of marketing approval in Europe and the…
New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder
Study concludes that psilocybin findings should be explored further in larger studies London, UK, April…
Chr. Hansen Holding A/S Interim report Q2 2020/21
Continued strong organic growth momentum leads to upwards narrowing of full-year organic growth guidance …
Roche’s Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA)
More than twice as many babies (61% vs. 29%) were able to sit without support…
Soleno Therapeutics Participates in Prader-Willi Syndrome (PWS) DCCR Town Hall
REDWOOD CITY, Calif., April 14, 2021 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
ImmuCell Closes $4,250,000 Equity Financing
PORTLAND, Maine, April 14, 2021 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”),…
Neuronetics Announces Retirement of Brian Farley and Appointment of Robert Cascella as Chairman of its Board of Directors
MALVERN, Pa., April 14, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical…
Biogen to Present Trial Design of Aducanumab EMBARK Re-Dosing Study in Poster Session at 2021 Virtual AAN Annual Meeting on April 17-22, 2021
CAMBRIDGE, Mass., April 14, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) today announced it will…
Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
Virtual KOL Event is scheduled for Tuesday, April 27th @ 10:30 AM ET AUSTIN, Texas,…
CytomX Therapeutics Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif., April 14, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a…
Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones
NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused…
Harrow Health Announces Preliminary First Quarter 2021 Financial Results
NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused…
Primo Nutraceuticals Inc. Corporate Update
VANCOUVER, British Columbia, April 14, 2021 (GLOBE NEWSWIRE) — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC:…